{"title": "Inotrem's phase 2 data spark hope for septic shock treatment", "author": "Gabrielle Masson", "url": "https://www.fiercebiotech.com/biotech/inotrems-phase-2b-data-sparks-hope-septic-shock-treatment", "hostname": "fiercebiotech.com", "description": "Rates of septic shock, a serious complication of sepsis, are on the rise. | Rates of septic shock, a serious complication of sepsis, are on the rise. With only antibiotics and symptomatic treatment available, biotech Inotrem hopes its investigational treatment could be the first mechanism-based therapy to treat the life-threatening condition.", "sitename": "FierceBiotech", "date": "2022-10-13", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}